KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 128 filers reported holding KYMERA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,314,914 | -53.1% | 238,483 | -22.4% | 0.00% | 0.0% |
Q2 2023 | $7,066,712 | +603.2% | 307,382 | +806.3% | 0.00% | – |
Q1 2023 | $1,004,990 | -79.0% | 33,918 | -82.3% | 0.00% | -100.0% |
Q4 2022 | $4,787,553 | +69.2% | 191,809 | +47.6% | 0.00% | – |
Q3 2022 | $2,829,000 | -13.4% | 129,919 | -21.6% | 0.00% | -100.0% |
Q2 2022 | $3,265,000 | -19.4% | 165,800 | +73.3% | 0.00% | 0.0% |
Q1 2022 | $4,049,000 | +55.1% | 95,658 | +132.8% | 0.00% | – |
Q4 2021 | $2,610,000 | -64.7% | 41,098 | -67.4% | 0.00% | -100.0% |
Q3 2021 | $7,402,000 | +144.3% | 126,028 | +101.7% | 0.00% | 0.0% |
Q2 2021 | $3,030,000 | -37.5% | 62,488 | -49.9% | 0.00% | 0.0% |
Q1 2021 | $4,847,000 | – | 124,725 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 5,984,736 | $149,379,011 | 17.99% |
Aquilo Capital Management, LLC | 629,411 | $15,710,099 | 5.90% |
BVF INC/IL | 4,692,604 | $117,127,396 | 4.94% |
Artal Group S.A. | 2,000,000 | $49,920 | 2.79% |
Redmile Group, LLC | 2,673,837 | $66,738,972 | 2.73% |
Avoro Capital Advisors LLC | 3,850,000 | $96,096,000 | 1.44% |
Deer Management Co. LLC | 615,895 | $15,372,739 | 1.42% |
AtonRa Partners | 27,125 | $677,040 | 0.86% |
Rock Springs Capital Management LP | 1,227,779 | $30,645,364 | 0.74% |
EcoR1 Capital, LLC | 796,093 | $19,870,481 | 0.60% |